You can buy or sell BMY and other stocks, options, ETFs, and crypto commission-free!
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. Read More The company was founded in August 1933 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Research And Development
Merck's Keytruda Vs. Bristol-Myers Squibb's Opdivo In Q1 And Beyond
Two big pharma titans are battling for supremacy in the field of oncology immunotherapy. From the looks of it, Kenilworth, New Jersey-based Merck & Co., Inc. (NYSE: MRK) may have the upper hand over Bristol-Myers Squibb Co (NYSE: BMY). Before poring over the specifics, here's what immunotherapy means: it's a type of cancer treatment that uses the body's immune system to put up a fight against cancer cells. Merck's Keytruda, or pembrolizumab, and BMY's Opdivo, or nivolumab, are both human, programmed deat...
Seeking AlphaMay 22
Bristol-Myers Squibb: Share Repurchases No Benefit To Shareholders
The reason for this dichotomy - the only way an investor can realize a return from an investment in shares is through receipt of dividends, and/or gains on sales, regardless of company performance.
Expected Jul 25, Pre-Market